COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Behnood Bikdeli; Mahesh V. Madhavan; David Jiménez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der‐Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang Tang; Yu Hu; Jay Giri; Mary Cushman; I. Quéré; Evangelos Dimakakos; C. Michael Gibson; Giuseppe Lippi; Emmanuel J. Favaloro; Jawed Fareed; Joseph A. Caprini; Alfonso Tafur; John Burton; Dominic P. Francese; Elizabeth Wang; Anna Falanga; Claire McLintock; Beverley J. Hunt; Alex C. Spyropoulos; Geoffrey D. Barnes; John W. Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A. Beckman; Philippe Gabríel Steg; Gregg W. Stone; Stephan Rosenkranz; Samuel Z. Goldhaber; Sahil A. Parikh; Manuel Monréal; Harlan M. Krumholz; Stavros Konstantinides; Jeffrey I. Weitz; Professor Gregory Lip

doi:10.1016/j.jacc.2020.04.031

Article1998

Antithrombotic Therapy for Venous Thromboembolic Disease

Thomas M. Hyers, Giancarlo Agnelli, Russell D. Hull, John G. Weg, Timothy A. Morris, Michel Samama, Victor F. Tapson

Preprint2021

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamín Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monréal, David Jiménez, Gregory Piazza, Sahil A. Parikh, Ajay J. Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, Professor Gregory Lip, Samuel Z. Goldhaber, Behnood Bikdeli

Article2022

Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19

Farhad Khimani, Adam J. Wolf, Braian Yoon, Amy Blancke, Coltin Gerhart, Dakota Endsley, Alleyna Dougherty, Anish Ray, Angelito F. Yango, Stuart D. Flynn, Professor Gregory Lip, Stevan A. Gonzalez, Mohanakrishnan Sathyamoorthy

Article2023

Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19

Tatjana Potpara, Dominick J. Angiolillo, Behnood Bikdeli, Davide Capodanno, Oana Cole, Angel Coz Yataco, Gheorghe‐Andrei Dan, Stephanie L. Harrison, Jonathan M. Iaccarino, Lisa K. Moores, George Ntaios, Professor Gregory Lip

Article2021

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamín Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monréal, David Jiménez, Gregory Piazza, Sahil A. Parikh, Ajay J. Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, ,

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Discussion(0)

Related publications

Antithrombotic Therapy for Venous Thromboembolic Disease

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19

Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19